2026 Meeting Materials, Vaccines and Related Biological Products Advisory Committee
The FDA established the primary landing page for the 2026 meeting materials of the Vaccines and Related Biological Products Advisory Committee (VRBPAC).
Manufacturers of vaccines and related biological products, as well as regulatory and clinical operations professionals involved in the vaccine approval process.
The VRBPAC provides expert advice on the safety and efficacy of vaccines and complex biologics; this repository serves as the central location for scientific data and materials that will influence FDA's decision-making throughout 2026. This indicates the start of the 2026 administrative cycle for vaccines, which may impact the timing of product reviews and public consultations.
Regulatory and Clinical teams should monitor this committee page for specific meeting agendas, briefing documents, and roster updates to align development programs with committee expectations for 2026.
This is the main page for the 2026 Meeting Materials, Vaccines and Related Biological Products Advisory Committee (VRBPAC).
Open in openFDA / FDA.gov